...
首页> 外文期刊>Cell death & disease. >N6-methyladenosine (m6A) methylation in ischemia–reperfusion injury
【24h】

N6-methyladenosine (m6A) methylation in ischemia–reperfusion injury

机译:N6-甲基腺苷(M6A)缺血再灌注损伤中的甲基化

获取原文
           

摘要

Ischemia-reperfusion (I/R) injury is common during surgery and often results in organ dysfunction. The mechanisms of I/R injury are complex, diverse, and not well understood. RNA methylation is a novel epigenetic modification that is involved in the regulation of various biological processes, such as immunity, response to DNA damage, tumorigenesis, metastasis, stem cell renewal, fat differentiation, circadian rhythms, cell development and differentiation, and cell division. Research on RNA modifications, specifically N6-methyladenosine (m6A), have confirmed that they are involved in the regulation of organ I/R injury. In this review, we summarized current understanding of the regulatory roles and significance of m6A RNA methylation in I/R injury in different organs.
机译:缺血再灌注(I / R)损伤在手术过程中是常见的,并且经常导致器官功能障碍。 I / R损伤的机制是复杂的,多样化的,并且不太了解。 RNA甲基化是一种新的表观遗传学改性,参与各种生物过程的调节,例如免疫力,对DNA损伤,肿瘤发生,转移,干细胞更新,脂肪分化,昼夜节律,细胞发育和分化和细胞分裂的调节。 RNA修饰,特别是N6-甲基腺苷(M6A)的研究证实它们参与了器官I / R损伤的调节。在本文中,我们总结了目前对不同器官I / R损伤中M6A RNA甲基化的调节作用和意义的理解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号